Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

Arcadia Biosciences, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

-- ARCADIA REVENUES INCREASE 11% YEAR OVER YEAR DRIVEN BY 24% GROWTH IN ZOLA  -- -- ARCADIA RECEIVES 2.7 MILLION SHARES OF STOCK IN ABVE --

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES SECOND QUARTER AND FIRST HALF 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

-- REVENUES INCREASE 22% YEAR OVER YEAR DRIVEN BY 90% GROWTH IN ZOLA  -- -- ARCADIA SELLS PATENTS FOR $750K AND ELIMINATES $1M IN LIABILITIES -- -- ROOSEVELT AGREEMENT AMENDED TO PROVIDE GREATER CERTAINTY REGARDING EXCHANGE RATIO -- DALLAS, MAY 08, 2025 (GLOBE NEWSWIRE) -- ARCADIA BIOSCIENCES, INC . (NASDAQ: RKDA), A PRODUCER AND MARKETER OF INNOVATIVE, PLANT-BASED HEALTH AND WELLNESS PRODUCTS, TODAY RELEASED ITS FINANCIAL AND BUSINESS RESULTS FOR THE FIRST QUARTER OF 2025.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES FIRST QUARTER 2025FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA) WILL RELEASE ITS FINANCIAL AND BUSINESS RESULTS FOR THE FIRST QUARTER OF 2025 ON MAY 8, 2025 AT 2:00 P.M. ET.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES DATE OF FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS CONFERENCE CALL

DALLAS--(BUSINESS WIRE)--ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA), A PRODUCER AND MARKETER OF INNOVATIVE, PLANT-BASED HEALTH AND WELLNESS PRODUCTS, TODAY RELEASED ITS FINANCIAL AND BUSINESS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR OF 2024. WE ARE EXTREMELY PLEASED WITH THE PROGRESS WE MADE IN 2024, PARTICULARLY IN THE SECOND HALF OF THE YEAR FOLLOWING THE SALE OF OUR GOODWHEAT ASSETS, SAID T.J. SCHAEFER, PRESIDENT AND CEO. OUR FOCUS ON ZOLA COCONUT WATER LED TO 80 PERCENT REVENUE GROW.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

DALLAS--(BUSINESS WIRE)--ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA), A PRODUCER AND MARKETER OF INNOVATIVE, PLANT-BASED HEALTH AND WELLNESS PRODUCTS, TODAY ANNOUNCED THAT IT WILL RELEASE ITS FINANCIAL AND BUSINESS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR OF 2024 AFTER MARKET CLOSE ON MARCH 20, 2025. THE COMPANY HAS SCHEDULED A CONFERENCE CALL FOR 4:30 P.M. EASTERN TIME (1:30 P.M. PACIFIC TIME) TO DISCUSS FOURTH-QUARTER AND YEAR-END RESULTS AND KEY STRATEGIC ACHIEVEMENTS. INTERESTED PARTICIPA.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES DATE OF FOURTH QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS CONFERENCE CALL

NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (KSF) ARE INVESTIGATING THE PROPOSED MERGER OF ARCADIA BIOSCIENCES, INC. (NASDAQCM: RKDA) AND ROOSEVELT RESOURCES LP. PURSUANT TO THE TERMS OF THE AGREEMENT, UPON COMPLETION OF THE MERGER, ARCADIA STOCKHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 10% OF THE COMBINED COMPANY. KSF IS SEEKING TO DETERMINE WHETHER THE MERGER AND THE PROCESS THAT LED TO IT ARE A.

ARCADIA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES MERGER OF ARCADIA BIOSCIENCES, INC. - RKDA

DALLAS--(BUSINESS WIRE)--ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA) AND ROOSEVELT RESOURCES LP ANNOUNCED TODAY THAT THEY HAVE ENTERED INTO A DEFINITIVE SECURITIES EXCHANGE AGREEMENT WHICH, WHEN COMPLETED, WILL COMBINE THE TWO COMPANIES IN AN ALL-STOCK TRANSACTION. UNDER THE TERMS OF THE AGREEMENT, ARCADIA WILL ISSUE TO THE PARTNERS OF ROOSEVELT SHARES OF ARCADIA COMMON STOCK AT THE CLOSING OF THE TRANSACTION IN EXCHANGE FOR ALL OF THE EQUITY INTERESTS IN ROOSEVELT. FOLLOWING THE CLOSING OF THE T.

ARCADIA BIOSCIENCES (RKDA) ENTERS INTO BUSINESS COMBINATION AGREEMENT WITH ROOSEVELT RESOURCES IN ALL-STOCK TRANSACTION

DALLAS--(BUSINESS WIRE)--ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA), A PRODUCER AND MARKETER OF INNOVATIVE, PLANT-BASED HEALTH AND WELLNESS PRODUCTS, TODAY ANNOUNCED THAT IT WILL RELEASE ITS FINANCIAL AND BUSINESS RESULTS FOR THE THIRD QUARTER OF 2024 AFTER MARKET CLOSE ON NOVEMBER 12, 2024. THE COMPANY HAS SCHEDULED A CONFERENCE CALL FOR 4:30 P.M. EASTERN TIME (1:30 P.M. PACIFIC TIME) TO DISCUSS THIRD-QUARTER RESULTS AND KEY STRATEGIC ACHIEVEMENTS. INTERESTED PARTICIPANTS CAN JOIN THE CONFERENC.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES DATE OF THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS CONFERENCE CALL

DALLAS--(BUSINESS WIRE)--ARCADIA BIOSCIENCES, INC. (NASDAQ: RKDA), A PRODUCER AND MARKETER OF INNOVATIVE, PLANT-BASED HEALTH AND WELLNESS PRODUCTS, TODAY RELEASED ITS FINANCIAL AND BUSINESS RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2024. THE SECOND QUARTER OF 2024 WAS A SIGNIFICANT TURNING POINT FOR ARCADIA AS WE TRANSFORM THE BUSINESS AND CHART OUR PATH TO BECOMING CASH FLOW POSITIVE, SAID T.J. SCHAEFER, PRESIDENT AND CEO. WE MONETIZED OUR WHEAT IP THROUGH TWO TRANSACTIONS: SELLING.

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

LOS ANGELES--(BUSINESS WIRE)--PRIME THERAPEUTICS FAILS TO SILENCE AHF IN PBM PRICE-FIXING ARBITRATION.

Arcadia Biosciences, Inc.

RKDA

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Arcadia Biosciences, Inc.

RKDA.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

RKDA